Search Results - D. Yu. Grebenkin
- Showing 1 - 11 results of 11
-
1
MODERN APPROACHES OF DISSOLUTION PROFILE TEST (REVIEW) by D. Yu. Grebenkin, Ya. M. Stanishevskiy, I. E. Shohin
Published 2019-01-01
Article -
2
RETROSPECTIVE OF DISSOLUTION TEST OF SOLID DOSAGE FORMS (REVIEW) by D. Yu. Grebenkin, Ya. M. Stanishevskiy, I. E. Shohin, E. A. Malashenko
Published 2019-01-01
Article -
3
-
4
-
5
-
6
-
7
-
8
Pharmacokinetic and Bioequivalence Study of the Two-component Drug Product "Ezetimibe + rosuvastatin" (JSC "Sanofi-aventis group", Russia): Resuts and Experience with the Use of En... by A. L. Khokhlov, D. Yu. Grebenkin, E. K. Faeva, V. I. Kazey, A. A. Khokhlov, A. E. Miroshnikov, O. V. Lebedeva
Published 2023-02-01
Article -
9
Bioequivalence study of fixed-dose combination Losartan + amlodipine + rosuvastatin Sanofi in comparison with coadministered fixed- dose combination Lozap® AM and monocomponent dru... by A. L. Khokhlov, D. Yu. Grebenkin, E. K. Faeva, V. I. Kazey, A. A. Khokhlov, A. E. Miroshnikov, O. V. Lebedeva
Published 2022-05-01
Article -
10
DEVELOPMENT AND VALIDATION OF A METHOD FOR DETERMINING NEUTRALIZING ANTIBODIES TO PEMBROLIZUMAB IN HUMAN SERUM BASED ON INHIBITION OF BINDING OF PEMBROLIZUMAB TO ITS PD-1 TARGET BY... by A. M. Kudryashova, D. Yu. Grebenkin, M. Yu. Samsonov, O. V. Filon, V. A. Razzhivina, M. G. Chernobrovkin, O. V. Borisova
Published 2019-08-01
Article -
11